Massimiliano Clamer

Company: Immagina Biotechnology Srl

Job title: Founder & Chief Executive Officer

Seminars:

Overcoming Limitations in RNA-Based Therapies: A Case Study on Cutaneous Squamous Cell Carcinoma Clinical Data 11:00 am

Immagina Biotechnology has pioneered integrated technologies to study RNA processing and translation in action By combining advanced methods for RiboSeq, tRNAseq, and tRNA fragment analysis, we identified a novel biomarker for Minimal Residual Disease in cutaneous squamous cell carcinoma This biomarker also presents significant potential as a drug target, opening new avenues for therapeutic developmentRead more

day: Day 2 Track 1 AM

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You’ll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.